Roberto Silva-Rojas, Natalia Vicente, Manuel Gavilán-Herrera, Verónica Labrador-Cantarero, Jon Sicilia, Olga Giménez-Sáez, Andra C. Dumitru, Mateo I. Sánchez, Mara Gato-Vilaseca, Diana Velázquez-Carreras, Juan Antonio López, Jesús Vázquez, Elías Herrero-Galán, Miguel A. López-Unzu, Maria Rosaria Pricolo, Jorge Alegre-Cebollada
{"title":"Mechanically knocking out titin reveals protein tension loss as a trigger of muscle disease","authors":"Roberto Silva-Rojas, Natalia Vicente, Manuel Gavilán-Herrera, Verónica Labrador-Cantarero, Jon Sicilia, Olga Giménez-Sáez, Andra C. Dumitru, Mateo I. Sánchez, Mara Gato-Vilaseca, Diana Velázquez-Carreras, Juan Antonio López, Jesús Vázquez, Elías Herrero-Galán, Miguel A. López-Unzu, Maria Rosaria Pricolo, Jorge Alegre-Cebollada","doi":"10.1038/s41551-025-01403-x","DOIUrl":null,"url":null,"abstract":"<p>Titin, the elastic protein scaffold of muscle sarcomeres, has multifunctional roles in mechanosignalling and is implicated in muscle disease. However, the consequences of disrupting titin’s mechanical function in vivo remain incompletely understood. Here, by leveraging site-directed polypeptide severing as a ‘mechanical knock-out’ method for abolishing force transmission across titin, we show that the loss of titin tension in homozygous mechanically knocked-out muscles reduces force generation and induces severe atrophy and widespread transcriptional dysregulation. Although mechanically knocked-out myofibres persist, they shrink and undergo progressive sarcomere depletion, which correlates with the rapid upregulation of muscle-specific RING finger protein 1 (MuRF1) and with altered levels of other titin-associated atrophy regulators. The affected fibres also exhibit mitochondrial aggregation and myonuclei internalization, preceded by desmin mislocalization. Heterozygous mechanically knocked-out muscles show milder phenotypes that closely resemble titin-related human myopathy. Our findings suggest that slack titin molecules drive muscle disease, potentially through mechanisms shared with other mechanical proteins.</p>","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":"4 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41551-025-01403-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Titin, the elastic protein scaffold of muscle sarcomeres, has multifunctional roles in mechanosignalling and is implicated in muscle disease. However, the consequences of disrupting titin’s mechanical function in vivo remain incompletely understood. Here, by leveraging site-directed polypeptide severing as a ‘mechanical knock-out’ method for abolishing force transmission across titin, we show that the loss of titin tension in homozygous mechanically knocked-out muscles reduces force generation and induces severe atrophy and widespread transcriptional dysregulation. Although mechanically knocked-out myofibres persist, they shrink and undergo progressive sarcomere depletion, which correlates with the rapid upregulation of muscle-specific RING finger protein 1 (MuRF1) and with altered levels of other titin-associated atrophy regulators. The affected fibres also exhibit mitochondrial aggregation and myonuclei internalization, preceded by desmin mislocalization. Heterozygous mechanically knocked-out muscles show milder phenotypes that closely resemble titin-related human myopathy. Our findings suggest that slack titin molecules drive muscle disease, potentially through mechanisms shared with other mechanical proteins.
期刊介绍:
Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.